IBD Duration Tied to Cholangiocarcinoma RiskIBD Duration Tied to Cholangiocarcinoma Risk
The duration of inflammatory bowel disease (IBD) is associated with an increased risk of cholangiocarcinoma in patients who also have primary sclerosing cholangitis, according to researchers at the Mayo Clinic in Rochester, Minnesota. Reuters Health Information
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Gastroenterology News Source Type: news
More News: Bile Duct Cancer | Cholangiocarcinoma | Gastroenterology | Health | Inflammatory Bowel Disease